Cargando…
What is the position of pulmonary arterial hypertension-specific drug therapy in patients with Eisenmenger syndrome: A systematic review and meta-analysis
BACKGROUND: It is commonly reported a limitation of therapeutic strategy in Eisenmenger syndrome (ES) historically. This qualitative systematic review is conducted to evaluate the safety and efficacy of pulmonary arterial hypertension-specific drug therapy (PAH-SDT) for ES patients for a clinical th...
Autores principales: | Li, Qiang, Kuang, Hong-Yu, Wu, Yu-Hao, Lu, Tie-Wei, Yi, Qi-Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531184/ https://www.ncbi.nlm.nih.gov/pubmed/31096477 http://dx.doi.org/10.1097/MD.0000000000015632 |
Ejemplares similares
-
Primary Presentation of Pulmonary Hypertension in the Peripartum: Preparing for Patients With Eisenmenger Physiology
por: Countouris, Malamo E., et al.
Publicado: (2020) -
Thrombosis of aneurysmal pulmonary arteries in patent ductus arteriosus with Eisenmenger syndrome
por: Bhattacharya, Deepanjan, et al.
Publicado: (2022) -
Pulmonary Arterial Thrombosis in a Patient With an Atrial Septal Defect and Eisenmenger Syndrome
por: Lee, Ching-Wei, et al.
Publicado: (2012) -
Eisenmenger syndrome
por: de Campos, Fernando Peixoto Ferraz, et al.
Publicado: (2017) -
The efficiency of endothelin receptor antagonist bosentan for pulmonary arterial hypertension associated with congenital heart disease: A systematic review and meta-analysis
por: Kuang, Hong-Yu, et al.
Publicado: (2018)